PMC:7301188 / 17700-19651 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"456","span":{"begin":533,"end":536},"obj":"Gene"},{"id":"457","span":{"begin":199,"end":202},"obj":"Gene"},{"id":"460","span":{"begin":32,"end":35},"obj":"Gene"},{"id":"461","span":{"begin":37,"end":40},"obj":"Gene"}],"attributes":[{"id":"A456","pred":"tao:has_database_id","subj":"456","obj":"Gene:58492"},{"id":"A457","pred":"tao:has_database_id","subj":"457","obj":"Gene:1645"},{"id":"A460","pred":"tao:has_database_id","subj":"460","obj":"Gene:1645"},{"id":"A461","pred":"tao:has_database_id","subj":"461","obj":"Gene:58492"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Table 2 The first detection of DD1, PT1, APTT1, Fg1, and clinical classification.\nParameters The first time clinical classifications (n, %) Total\nMild/ordinary cases Severe cases Critical cases\nDD1 (M ± SD) 0.85 ± 1.68 1.78 ± 4.40 3.86 ± 7.93 1.97 ± 5.01\n \u003c0.55 28 (24.3%) 26 (22.6%) 11 (9.6%) 65 (56.5%)\n 0.55-1.10 4 (3.4%) 8 (6.9%) 3 (2.6%) 15 (13.0%)\n \u003e1.10 7 (6.0%) 14 (12.2%) 14 (12.2%) 35 (30.5%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 9.505 P \u003c 0.05\n r, P r = 0.268 P \u003c 0.01\nPT1 (M ± SD) 12.34 ± 1.91 12.14 ± 1.16 13.70 ± 3.38 12.59 ± 2.21\n \u003c9.2 0 (0%) 0 (0%) 0 (0%) 0 (0%)\n 9.20-15.0 37 (32.1%) 47 (40.9%) 23 (20.0%) 107 (93.0%)\n \u003e15 2 (1.7%) 1 (0.8%) 5 (4.3%) 8 (7.0%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 7.013 P \u003c 0.05\n r, P r = 0.162 P \u003e 0.05\nAPTT1 (M ± SD) 3.49 ± 9.17 36.47 ± 9.29 36.98 ± 8.60 35.59 ± 9.13\n \u003c21.00 1 (0.8%) 0 (0%) 1 (0.8%) 2 (1.7%)\n 21.00-37.00 27 (23.5%) 26 (22.6%) 13 (11.3%) 66 (57.4%)\n \u003e37.00 11 (9.6%) 22 (19.1%) 14 (12.2%) 47 (40.9%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 5.545 P \u003e 0.05\n r, P r = 0.171 P \u003e 0.05\nFg1 (M ± SD) 4.38 ± 1.15 4.93 ± 1.26 4.40 ± 2.07 4.61 ± 1.48\n \u003c2.00 1 (0.8%) 0 (0%) 6 (5.2%) 7 (6.1%)\n 2.00-4.00 16 (13.9%) 13 (11.3%) 5 (4.3%) 34 (29.6%)\n \u003e4.00 22 (19.1%) 35 (30.4%) 17 (14.8%) 74 (64.3%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 18.661 P \u003c 0.01\n r, P r = 0.006 P \u003e 0.05\nTT1 (M ± SD)\n \u003c10 0 (0%) 1 (0.8%) 0 (0%) 1 (0.8%)\n 10-20 37 (32.2%) 47 (40.9%) 26 (22.7%) 110 (95.8%)\n \u003e20 2 (1.7%) 0 (0%) 2 (1.7%) 4 (3.4%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.4%) 115\n χ2, P χ 2 = 4.503 P \u003e 0.05\n r, P r = 0.175 P \u003e 0.05\nNormal reference values: DD (\u003c0.55 mg/L); PT (9.20-15 sec); APTT (21.00-37.00 sec); TT (10-20 sec); Fg (2.00-4.00 g/L). ∗P value was calculated by a 2-sided test."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T139","span":{"begin":1814,"end":1816},"obj":"Disease"}],"attributes":[{"id":"A139","pred":"mondo_id","subj":"T139","obj":"http://purl.obolibrary.org/obo/MONDO_0009107"},{"id":"A140","pred":"mondo_id","subj":"T139","obj":"http://purl.obolibrary.org/obo/MONDO_0015613"}],"text":"Table 2 The first detection of DD1, PT1, APTT1, Fg1, and clinical classification.\nParameters The first time clinical classifications (n, %) Total\nMild/ordinary cases Severe cases Critical cases\nDD1 (M ± SD) 0.85 ± 1.68 1.78 ± 4.40 3.86 ± 7.93 1.97 ± 5.01\n \u003c0.55 28 (24.3%) 26 (22.6%) 11 (9.6%) 65 (56.5%)\n 0.55-1.10 4 (3.4%) 8 (6.9%) 3 (2.6%) 15 (13.0%)\n \u003e1.10 7 (6.0%) 14 (12.2%) 14 (12.2%) 35 (30.5%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 9.505 P \u003c 0.05\n r, P r = 0.268 P \u003c 0.01\nPT1 (M ± SD) 12.34 ± 1.91 12.14 ± 1.16 13.70 ± 3.38 12.59 ± 2.21\n \u003c9.2 0 (0%) 0 (0%) 0 (0%) 0 (0%)\n 9.20-15.0 37 (32.1%) 47 (40.9%) 23 (20.0%) 107 (93.0%)\n \u003e15 2 (1.7%) 1 (0.8%) 5 (4.3%) 8 (7.0%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 7.013 P \u003c 0.05\n r, P r = 0.162 P \u003e 0.05\nAPTT1 (M ± SD) 3.49 ± 9.17 36.47 ± 9.29 36.98 ± 8.60 35.59 ± 9.13\n \u003c21.00 1 (0.8%) 0 (0%) 1 (0.8%) 2 (1.7%)\n 21.00-37.00 27 (23.5%) 26 (22.6%) 13 (11.3%) 66 (57.4%)\n \u003e37.00 11 (9.6%) 22 (19.1%) 14 (12.2%) 47 (40.9%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 5.545 P \u003e 0.05\n r, P r = 0.171 P \u003e 0.05\nFg1 (M ± SD) 4.38 ± 1.15 4.93 ± 1.26 4.40 ± 2.07 4.61 ± 1.48\n \u003c2.00 1 (0.8%) 0 (0%) 6 (5.2%) 7 (6.1%)\n 2.00-4.00 16 (13.9%) 13 (11.3%) 5 (4.3%) 34 (29.6%)\n \u003e4.00 22 (19.1%) 35 (30.4%) 17 (14.8%) 74 (64.3%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 18.661 P \u003c 0.01\n r, P r = 0.006 P \u003e 0.05\nTT1 (M ± SD)\n \u003c10 0 (0%) 1 (0.8%) 0 (0%) 1 (0.8%)\n 10-20 37 (32.2%) 47 (40.9%) 26 (22.7%) 110 (95.8%)\n \u003e20 2 (1.7%) 0 (0%) 2 (1.7%) 4 (3.4%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.4%) 115\n χ2, P χ 2 = 4.503 P \u003e 0.05\n r, P r = 0.175 P \u003e 0.05\nNormal reference values: DD (\u003c0.55 mg/L); PT (9.20-15 sec); APTT (21.00-37.00 sec); TT (10-20 sec); Fg (2.00-4.00 g/L). ∗P value was calculated by a 2-sided test."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T139","span":{"begin":296,"end":298},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T140","span":{"begin":413,"end":415},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T141","span":{"begin":444,"end":446},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T142","span":{"begin":765,"end":767},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T143","span":{"begin":984,"end":986},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"},{"id":"T144","span":{"begin":1040,"end":1042},"obj":"http://purl.obolibrary.org/obo/CLO_0053733"},{"id":"T145","span":{"begin":1051,"end":1053},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T146","span":{"begin":1106,"end":1108},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T147","span":{"begin":1351,"end":1353},"obj":"http://purl.obolibrary.org/obo/CLO_0001302"},{"id":"T148","span":{"begin":1370,"end":1372},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T149","span":{"begin":1382,"end":1384},"obj":"http://purl.obolibrary.org/obo/CLO_0001000"},{"id":"T150","span":{"begin":1437,"end":1439},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T151","span":{"begin":1585,"end":1591},"obj":"http://purl.obolibrary.org/obo/CLO_0001174"},{"id":"T152","span":{"begin":1700,"end":1702},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"},{"id":"T153","span":{"begin":1873,"end":1875},"obj":"http://purl.obolibrary.org/obo/CLO_0009421"},{"id":"T154","span":{"begin":1873,"end":1875},"obj":"http://purl.obolibrary.org/obo/CLO_0052184"},{"id":"T155","span":{"begin":1873,"end":1875},"obj":"http://purl.obolibrary.org/obo/CLO_0052185"},{"id":"T156","span":{"begin":1936,"end":1939},"obj":"http://purl.obolibrary.org/obo/CLO_0001562"},{"id":"T157","span":{"begin":1936,"end":1939},"obj":"http://purl.obolibrary.org/obo/CLO_0001563"},{"id":"T158","span":{"begin":1946,"end":1950},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Table 2 The first detection of DD1, PT1, APTT1, Fg1, and clinical classification.\nParameters The first time clinical classifications (n, %) Total\nMild/ordinary cases Severe cases Critical cases\nDD1 (M ± SD) 0.85 ± 1.68 1.78 ± 4.40 3.86 ± 7.93 1.97 ± 5.01\n \u003c0.55 28 (24.3%) 26 (22.6%) 11 (9.6%) 65 (56.5%)\n 0.55-1.10 4 (3.4%) 8 (6.9%) 3 (2.6%) 15 (13.0%)\n \u003e1.10 7 (6.0%) 14 (12.2%) 14 (12.2%) 35 (30.5%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 9.505 P \u003c 0.05\n r, P r = 0.268 P \u003c 0.01\nPT1 (M ± SD) 12.34 ± 1.91 12.14 ± 1.16 13.70 ± 3.38 12.59 ± 2.21\n \u003c9.2 0 (0%) 0 (0%) 0 (0%) 0 (0%)\n 9.20-15.0 37 (32.1%) 47 (40.9%) 23 (20.0%) 107 (93.0%)\n \u003e15 2 (1.7%) 1 (0.8%) 5 (4.3%) 8 (7.0%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 7.013 P \u003c 0.05\n r, P r = 0.162 P \u003e 0.05\nAPTT1 (M ± SD) 3.49 ± 9.17 36.47 ± 9.29 36.98 ± 8.60 35.59 ± 9.13\n \u003c21.00 1 (0.8%) 0 (0%) 1 (0.8%) 2 (1.7%)\n 21.00-37.00 27 (23.5%) 26 (22.6%) 13 (11.3%) 66 (57.4%)\n \u003e37.00 11 (9.6%) 22 (19.1%) 14 (12.2%) 47 (40.9%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 5.545 P \u003e 0.05\n r, P r = 0.171 P \u003e 0.05\nFg1 (M ± SD) 4.38 ± 1.15 4.93 ± 1.26 4.40 ± 2.07 4.61 ± 1.48\n \u003c2.00 1 (0.8%) 0 (0%) 6 (5.2%) 7 (6.1%)\n 2.00-4.00 16 (13.9%) 13 (11.3%) 5 (4.3%) 34 (29.6%)\n \u003e4.00 22 (19.1%) 35 (30.4%) 17 (14.8%) 74 (64.3%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 18.661 P \u003c 0.01\n r, P r = 0.006 P \u003e 0.05\nTT1 (M ± SD)\n \u003c10 0 (0%) 1 (0.8%) 0 (0%) 1 (0.8%)\n 10-20 37 (32.2%) 47 (40.9%) 26 (22.7%) 110 (95.8%)\n \u003e20 2 (1.7%) 0 (0%) 2 (1.7%) 4 (3.4%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.4%) 115\n χ2, P χ 2 = 4.503 P \u003e 0.05\n r, P r = 0.175 P \u003e 0.05\nNormal reference values: DD (\u003c0.55 mg/L); PT (9.20-15 sec); APTT (21.00-37.00 sec); TT (10-20 sec); Fg (2.00-4.00 g/L). ∗P value was calculated by a 2-sided test."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T96","span":{"begin":208,"end":210},"obj":"Chemical"},{"id":"T97","span":{"begin":542,"end":544},"obj":"Chemical"},{"id":"T98","span":{"begin":865,"end":867},"obj":"Chemical"},{"id":"T99","span":{"begin":1204,"end":1206},"obj":"Chemical"},{"id":"T100","span":{"begin":1536,"end":1538},"obj":"Chemical"},{"id":"T101","span":{"begin":1814,"end":1816},"obj":"Chemical"},{"id":"T102","span":{"begin":1831,"end":1833},"obj":"Chemical"},{"id":"T103","span":{"begin":1873,"end":1875},"obj":"Chemical"}],"attributes":[{"id":"A96","pred":"chebi_id","subj":"T96","obj":"http://purl.obolibrary.org/obo/CHEBI_74807"},{"id":"A97","pred":"chebi_id","subj":"T97","obj":"http://purl.obolibrary.org/obo/CHEBI_74807"},{"id":"A98","pred":"chebi_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/CHEBI_74807"},{"id":"A99","pred":"chebi_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/CHEBI_74807"},{"id":"A100","pred":"chebi_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/CHEBI_74807"},{"id":"A101","pred":"chebi_id","subj":"T101","obj":"http://purl.obolibrary.org/obo/CHEBI_73446"},{"id":"A102","pred":"chebi_id","subj":"T102","obj":"http://purl.obolibrary.org/obo/CHEBI_141395"},{"id":"A103","pred":"chebi_id","subj":"T103","obj":"http://purl.obolibrary.org/obo/CHEBI_73665"}],"text":"Table 2 The first detection of DD1, PT1, APTT1, Fg1, and clinical classification.\nParameters The first time clinical classifications (n, %) Total\nMild/ordinary cases Severe cases Critical cases\nDD1 (M ± SD) 0.85 ± 1.68 1.78 ± 4.40 3.86 ± 7.93 1.97 ± 5.01\n \u003c0.55 28 (24.3%) 26 (22.6%) 11 (9.6%) 65 (56.5%)\n 0.55-1.10 4 (3.4%) 8 (6.9%) 3 (2.6%) 15 (13.0%)\n \u003e1.10 7 (6.0%) 14 (12.2%) 14 (12.2%) 35 (30.5%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 9.505 P \u003c 0.05\n r, P r = 0.268 P \u003c 0.01\nPT1 (M ± SD) 12.34 ± 1.91 12.14 ± 1.16 13.70 ± 3.38 12.59 ± 2.21\n \u003c9.2 0 (0%) 0 (0%) 0 (0%) 0 (0%)\n 9.20-15.0 37 (32.1%) 47 (40.9%) 23 (20.0%) 107 (93.0%)\n \u003e15 2 (1.7%) 1 (0.8%) 5 (4.3%) 8 (7.0%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 7.013 P \u003c 0.05\n r, P r = 0.162 P \u003e 0.05\nAPTT1 (M ± SD) 3.49 ± 9.17 36.47 ± 9.29 36.98 ± 8.60 35.59 ± 9.13\n \u003c21.00 1 (0.8%) 0 (0%) 1 (0.8%) 2 (1.7%)\n 21.00-37.00 27 (23.5%) 26 (22.6%) 13 (11.3%) 66 (57.4%)\n \u003e37.00 11 (9.6%) 22 (19.1%) 14 (12.2%) 47 (40.9%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 5.545 P \u003e 0.05\n r, P r = 0.171 P \u003e 0.05\nFg1 (M ± SD) 4.38 ± 1.15 4.93 ± 1.26 4.40 ± 2.07 4.61 ± 1.48\n \u003c2.00 1 (0.8%) 0 (0%) 6 (5.2%) 7 (6.1%)\n 2.00-4.00 16 (13.9%) 13 (11.3%) 5 (4.3%) 34 (29.6%)\n \u003e4.00 22 (19.1%) 35 (30.4%) 17 (14.8%) 74 (64.3%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 18.661 P \u003c 0.01\n r, P r = 0.006 P \u003e 0.05\nTT1 (M ± SD)\n \u003c10 0 (0%) 1 (0.8%) 0 (0%) 1 (0.8%)\n 10-20 37 (32.2%) 47 (40.9%) 26 (22.7%) 110 (95.8%)\n \u003e20 2 (1.7%) 0 (0%) 2 (1.7%) 4 (3.4%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.4%) 115\n χ2, P χ 2 = 4.503 P \u003e 0.05\n r, P r = 0.175 P \u003e 0.05\nNormal reference values: DD (\u003c0.55 mg/L); PT (9.20-15 sec); APTT (21.00-37.00 sec); TT (10-20 sec); Fg (2.00-4.00 g/L). ∗P value was calculated by a 2-sided test."}

    LitCovid-PD-GlycoEpitope

    {"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T14","span":{"begin":32,"end":35},"obj":"GlycoEpitope"},{"id":"T15","span":{"begin":199,"end":202},"obj":"GlycoEpitope"}],"attributes":[{"id":"A14","pred":"glyco_epitope_db_id","subj":"T14","obj":"http://www.glycoepitope.jp/epitopes/AN0523"},{"id":"A15","pred":"glyco_epitope_db_id","subj":"T15","obj":"http://www.glycoepitope.jp/epitopes/AN0523"}],"text":"Table 2 The first detection of DD1, PT1, APTT1, Fg1, and clinical classification.\nParameters The first time clinical classifications (n, %) Total\nMild/ordinary cases Severe cases Critical cases\nDD1 (M ± SD) 0.85 ± 1.68 1.78 ± 4.40 3.86 ± 7.93 1.97 ± 5.01\n \u003c0.55 28 (24.3%) 26 (22.6%) 11 (9.6%) 65 (56.5%)\n 0.55-1.10 4 (3.4%) 8 (6.9%) 3 (2.6%) 15 (13.0%)\n \u003e1.10 7 (6.0%) 14 (12.2%) 14 (12.2%) 35 (30.5%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 9.505 P \u003c 0.05\n r, P r = 0.268 P \u003c 0.01\nPT1 (M ± SD) 12.34 ± 1.91 12.14 ± 1.16 13.70 ± 3.38 12.59 ± 2.21\n \u003c9.2 0 (0%) 0 (0%) 0 (0%) 0 (0%)\n 9.20-15.0 37 (32.1%) 47 (40.9%) 23 (20.0%) 107 (93.0%)\n \u003e15 2 (1.7%) 1 (0.8%) 5 (4.3%) 8 (7.0%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 7.013 P \u003c 0.05\n r, P r = 0.162 P \u003e 0.05\nAPTT1 (M ± SD) 3.49 ± 9.17 36.47 ± 9.29 36.98 ± 8.60 35.59 ± 9.13\n \u003c21.00 1 (0.8%) 0 (0%) 1 (0.8%) 2 (1.7%)\n 21.00-37.00 27 (23.5%) 26 (22.6%) 13 (11.3%) 66 (57.4%)\n \u003e37.00 11 (9.6%) 22 (19.1%) 14 (12.2%) 47 (40.9%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 5.545 P \u003e 0.05\n r, P r = 0.171 P \u003e 0.05\nFg1 (M ± SD) 4.38 ± 1.15 4.93 ± 1.26 4.40 ± 2.07 4.61 ± 1.48\n \u003c2.00 1 (0.8%) 0 (0%) 6 (5.2%) 7 (6.1%)\n 2.00-4.00 16 (13.9%) 13 (11.3%) 5 (4.3%) 34 (29.6%)\n \u003e4.00 22 (19.1%) 35 (30.4%) 17 (14.8%) 74 (64.3%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 18.661 P \u003c 0.01\n r, P r = 0.006 P \u003e 0.05\nTT1 (M ± SD)\n \u003c10 0 (0%) 1 (0.8%) 0 (0%) 1 (0.8%)\n 10-20 37 (32.2%) 47 (40.9%) 26 (22.7%) 110 (95.8%)\n \u003e20 2 (1.7%) 0 (0%) 2 (1.7%) 4 (3.4%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.4%) 115\n χ2, P χ 2 = 4.503 P \u003e 0.05\n r, P r = 0.175 P \u003e 0.05\nNormal reference values: DD (\u003c0.55 mg/L); PT (9.20-15 sec); APTT (21.00-37.00 sec); TT (10-20 sec); Fg (2.00-4.00 g/L). ∗P value was calculated by a 2-sided test."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T163","span":{"begin":0,"end":82},"obj":"Sentence"},{"id":"T164","span":{"begin":83,"end":148},"obj":"Sentence"},{"id":"T165","span":{"begin":149,"end":198},"obj":"Sentence"},{"id":"T166","span":{"begin":199,"end":263},"obj":"Sentence"},{"id":"T167","span":{"begin":264,"end":317},"obj":"Sentence"},{"id":"T168","span":{"begin":318,"end":370},"obj":"Sentence"},{"id":"T169","span":{"begin":371,"end":423},"obj":"Sentence"},{"id":"T170","span":{"begin":424,"end":471},"obj":"Sentence"},{"id":"T171","span":{"begin":472,"end":503},"obj":"Sentence"},{"id":"T172","span":{"begin":504,"end":532},"obj":"Sentence"},{"id":"T173","span":{"begin":533,"end":601},"obj":"Sentence"},{"id":"T174","span":{"begin":602,"end":639},"obj":"Sentence"},{"id":"T175","span":{"begin":640,"end":699},"obj":"Sentence"},{"id":"T176","span":{"begin":700,"end":744},"obj":"Sentence"},{"id":"T177","span":{"begin":745,"end":792},"obj":"Sentence"},{"id":"T178","span":{"begin":793,"end":824},"obj":"Sentence"},{"id":"T179","span":{"begin":825,"end":853},"obj":"Sentence"},{"id":"T180","span":{"begin":854,"end":923},"obj":"Sentence"},{"id":"T181","span":{"begin":924,"end":969},"obj":"Sentence"},{"id":"T182","span":{"begin":970,"end":1030},"obj":"Sentence"},{"id":"T183","span":{"begin":1031,"end":1085},"obj":"Sentence"},{"id":"T184","span":{"begin":1086,"end":1133},"obj":"Sentence"},{"id":"T185","span":{"begin":1134,"end":1165},"obj":"Sentence"},{"id":"T186","span":{"begin":1166,"end":1194},"obj":"Sentence"},{"id":"T187","span":{"begin":1195,"end":1259},"obj":"Sentence"},{"id":"T188","span":{"begin":1260,"end":1304},"obj":"Sentence"},{"id":"T189","span":{"begin":1305,"end":1361},"obj":"Sentence"},{"id":"T190","span":{"begin":1362,"end":1416},"obj":"Sentence"},{"id":"T191","span":{"begin":1417,"end":1464},"obj":"Sentence"},{"id":"T192","span":{"begin":1465,"end":1497},"obj":"Sentence"},{"id":"T193","span":{"begin":1498,"end":1526},"obj":"Sentence"},{"id":"T194","span":{"begin":1527,"end":1539},"obj":"Sentence"},{"id":"T195","span":{"begin":1540,"end":1580},"obj":"Sentence"},{"id":"T196","span":{"begin":1581,"end":1636},"obj":"Sentence"},{"id":"T197","span":{"begin":1637,"end":1679},"obj":"Sentence"},{"id":"T198","span":{"begin":1680,"end":1727},"obj":"Sentence"},{"id":"T199","span":{"begin":1728,"end":1759},"obj":"Sentence"},{"id":"T200","span":{"begin":1760,"end":1788},"obj":"Sentence"},{"id":"T201","span":{"begin":1789,"end":1951},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Table 2 The first detection of DD1, PT1, APTT1, Fg1, and clinical classification.\nParameters The first time clinical classifications (n, %) Total\nMild/ordinary cases Severe cases Critical cases\nDD1 (M ± SD) 0.85 ± 1.68 1.78 ± 4.40 3.86 ± 7.93 1.97 ± 5.01\n \u003c0.55 28 (24.3%) 26 (22.6%) 11 (9.6%) 65 (56.5%)\n 0.55-1.10 4 (3.4%) 8 (6.9%) 3 (2.6%) 15 (13.0%)\n \u003e1.10 7 (6.0%) 14 (12.2%) 14 (12.2%) 35 (30.5%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 9.505 P \u003c 0.05\n r, P r = 0.268 P \u003c 0.01\nPT1 (M ± SD) 12.34 ± 1.91 12.14 ± 1.16 13.70 ± 3.38 12.59 ± 2.21\n \u003c9.2 0 (0%) 0 (0%) 0 (0%) 0 (0%)\n 9.20-15.0 37 (32.1%) 47 (40.9%) 23 (20.0%) 107 (93.0%)\n \u003e15 2 (1.7%) 1 (0.8%) 5 (4.3%) 8 (7.0%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 7.013 P \u003c 0.05\n r, P r = 0.162 P \u003e 0.05\nAPTT1 (M ± SD) 3.49 ± 9.17 36.47 ± 9.29 36.98 ± 8.60 35.59 ± 9.13\n \u003c21.00 1 (0.8%) 0 (0%) 1 (0.8%) 2 (1.7%)\n 21.00-37.00 27 (23.5%) 26 (22.6%) 13 (11.3%) 66 (57.4%)\n \u003e37.00 11 (9.6%) 22 (19.1%) 14 (12.2%) 47 (40.9%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 5.545 P \u003e 0.05\n r, P r = 0.171 P \u003e 0.05\nFg1 (M ± SD) 4.38 ± 1.15 4.93 ± 1.26 4.40 ± 2.07 4.61 ± 1.48\n \u003c2.00 1 (0.8%) 0 (0%) 6 (5.2%) 7 (6.1%)\n 2.00-4.00 16 (13.9%) 13 (11.3%) 5 (4.3%) 34 (29.6%)\n \u003e4.00 22 (19.1%) 35 (30.4%) 17 (14.8%) 74 (64.3%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.3%) 115\n χ2, P χ 2 = 18.661 P \u003c 0.01\n r, P r = 0.006 P \u003e 0.05\nTT1 (M ± SD)\n \u003c10 0 (0%) 1 (0.8%) 0 (0%) 1 (0.8%)\n 10-20 37 (32.2%) 47 (40.9%) 26 (22.7%) 110 (95.8%)\n \u003e20 2 (1.7%) 0 (0%) 2 (1.7%) 4 (3.4%)\n Total 39 (33.9%) 48 (41.7%) 28 (24.4%) 115\n χ2, P χ 2 = 4.503 P \u003e 0.05\n r, P r = 0.175 P \u003e 0.05\nNormal reference values: DD (\u003c0.55 mg/L); PT (9.20-15 sec); APTT (21.00-37.00 sec); TT (10-20 sec); Fg (2.00-4.00 g/L). ∗P value was calculated by a 2-sided test."}